Community Action Needed: Please respond to the NIH RFI
ZFIN ID: ZDB-PUB-170504-4
Waterborne exposure to BPS causes thyroid endocrine disruption in zebrafish larvae
Zhang, D.H., Zhou, E.X., Yang, Z.L.
Date: 2017
Source: PLoS One   12: e0176927 (Journal)
Registered Authors: Zhang, Danhua
Keywords: Zebrafish, Larvae, Thyroid-stimulating hormone, Thyroid, Thyroid hormones, Chemical disruption, Embryos, Endocrine system
MeSH Terms:
  • Animals
  • Dose-Response Relationship, Drug
  • Environmental Exposure/adverse effects
  • Hypothalamo-Hypophyseal System/drug effects
  • Hypothalamo-Hypophyseal System/physiology
  • Larva/drug effects
  • Larva/physiology
  • Phenols/adverse effects*
  • Sulfones/adverse effects*
  • Thyroid Gland/drug effects*
  • Thyroid Gland/embryology
  • Thyroid Gland/physiology
  • Thyrotropin/blood
  • Thyroxine/blood
  • Triiodothyronine/blood
  • Water Pollutants, Chemical/adverse effects
  • Zebrafish/embryology*
  • Zebrafish/physiology
PubMed: 28467477 Full text @ PLoS One
Bisphenol S (BPS) is widely used as a raw material in industry, resulting in its ubiquitous distribution in natural environment, including the aqueous environment. However, the effect of BPS on the thyroid endocrine system is largely unknown. In this study, zebrafish (Danio rerio) embryos were exposed to BPS at 1, 3, 10, and 30 μg/L, from 2 h post-fertilization (hpf) to 168hpf. Bioconcentration of BPS and whole-body thyroid hormones (THs), thyroid-stimulating hormone (TSH) concentrations as well as transcriptional profiling of key genes related to the hypothalamic-pituitary-thyroid (HPT) axis were examined. Chemical analysis indicated that BPS was accumulated in zebrafish larvae. Thyroxine (T4) and triiodothyronine (T3) levels were significantly decreased at ≥ 10 and 30 μg/L of BPS, respectively. However, TSH concentration was significantly induced in the 10 and 30 μg/L BPS-treated groups. After exposure to BPS, the mRNA expression of corticotrophin releasing hormone (crh) and thyroglobulin (tg) genes were up-regulated at ≥10 μg/L of BPS, in a dose-response manner. The transcription of genes involved in thyroid development (pax8) and synthesis (sodium/iodide symporter, slc5a5) were also significantly increased in the 30 μg/L of BPS treatment group. Moreover, exposure to 10 μg/L or higher concentration of BPS significantly up-regulated genes related to thyroid hormone metabolism (deiodinases, dio1, dio2 and uridinediphosphate glucoronosyltransferases, ugt1ab), which might be responsible for the altered THs levels. However, the transcript of transthyretin (ttr) was significantly down-regulated at ≥ 3 μg/L of BPS, while the mRNA levels of thyroid hormone receptors (trα and trβ) and dio3 remained unchanged. All the results indicated that exposure to BPS altered the whole-body THs and TSH concentrations and changed the expression profiling of key genes related to HPT axis, thus triggering thyroid endocrine disruption.